Literature DB >> 1917903

Comparative base specificity, stability, and lectin activity of two lectins from eggs of Rana catesbeiana and R. japonica and liver ribonuclease from R. catesbeiana.

Y Okabe1, N Katayama, M Iwama, H Watanabe, K Ohgi, M Irie, K Nitta, H Kawauchi, Y Takayanagi, F Oyama.   

Abstract

Two lectins with RNase activity obtained from eggs of Rana catesbeiana and R. japonica and RNase obtained from R. catesbeiana liver show 65-83% protein homology. The base specificity of these frog proteins was studied with 8 dinucleoside phosphates as substrates and 8 nucleotides as inhibitors. The base specificities of the B1 and B2 sites of these proteins are U greater than C and G greater than U greater than A, C, respectively. The three frog proteins are more resistant than RNase A to heat treatment, guanidine-HCl and pH-induced denaturation; i.e., they retain their native conformation up to at least 70 degrees C at pH 7.5. Differences in stability and base specificity among RNase A and the three frog proteins are discussed in relation to the primary structures. Although the two lectins agglutinate tumor cells (e.g., Ehrlich, S-180 and AH109A ascites carcinoma cells), the liver RNase has no such activity. Agglutination of AH109A cells by the two lectins is inhibited by nucleotides. Our results indicate that the agglutination sites are not identical with, but are related to, the active sites of the three frog proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917903     DOI: 10.1093/oxfordjournals.jbchem.a123457

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

Review 1.  Cancer chemotherapy--ribonucleases to the rescue.

Authors:  P A Leland; R T Raines
Journal:  Chem Biol       Date:  2001-05

2.  Agglutinins from aquatic insects--tumor cell agglutination activity.

Authors:  H Kawauchi; M Hosono; Y Takayanagi; K Nitta
Journal:  Experientia       Date:  1993-04-15

3.  Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog).

Authors:  Y D Liao; H C Huang; Y J Leu; C W Wei; P C Tang; S C Wang
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  1H, 15N and 13C resonance assignments and secondary structure of the liver ribonuclease from bullfrog Rana catesbeiana.

Authors:  N Y Su; Y D Liao; C F Chang; I Wanga; C Chena
Journal:  J Biomol NMR       Date:  2001-06       Impact factor: 2.835

5.  The secondary structure of a pyrimidine-guanine sequence-specific ribonuclease possessing cytotoxic activity from the oocytes of Rana catesbeiana.

Authors:  C Chen; K Hom; R F Huang; P J Chou; Y D Liao; T Huang
Journal:  J Biomol NMR       Date:  1996-10       Impact factor: 2.835

6.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Structural basis for catalysis by onconase.

Authors:  J Eugene Lee; Euiyoung Bae; Craig A Bingman; George N Phillips; Ronald T Raines
Journal:  J Mol Biol       Date:  2007-10-04       Impact factor: 5.469

8.  The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.

Authors:  You-Di Liao; Sui-Chi Wang; Ying-Jen Leu; Chiu-Feng Wang; Shu-Ting Chang; Yu-Ting Hong; Yun-Ru Pan; Chinpan Chen
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  Immunocytochemical localization of ribonuclease in yolk granules of adult Rana catesbeiana oocytes.

Authors:  J J Wang; P C Tang; S H Chao; C H Cheng; H J Ma; Y D Liao
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

10.  Involvement of ER stress in apoptosis induced by sialic acid-binding lectin (leczyme) from bullfrog eggs.

Authors:  Takeo Tatsuta; Masahiro Hosono; Yuki Miura; Shigeki Sugawara; Yukiko Kariya; Senitiroh Hakomori; Kazuo Nitta
Journal:  Int J Oncol       Date:  2013-10-04       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.